For Doctor Health Feed Book Appointment Book Lab Test Login
  • Dermotologist
  • General physician
  • Gynaecologist
  • Pediatrition
  • Sexologist
  • Homeopath
  • Diabetes
  • Hair Fall
  • Infertility Treatment
  • Knee Pain Treatment
  • ACNE Treatment
  • Pregnancy
  • Delhi
  • Hyderabad
  • Kolkata
  • Pune
  • Banglore
  • Mumbai
  • Chennai
  • Kochin
  • Madurai
  • Ranchi
  • Jamshedpur
  • Lakhnaw
  • Kanpur

Hereditary Breast and Ovarian Cancer : Overview

What is Hereditary Breast and Ovarian Cancer?

A diagnosis of Hereditary Breast and Ovarian Cancer Syndrome (HBOC) is taken into account 
when there are multiple cases of carcinoma and/or ovarian cancer on an equivalent side of the family. the prospect that a family has HBOC increases in any of those situations:


Ø    1 or more women are diagnosed at age 45 or younger

Ø    1 or more women are diagnosed with carcinoma before age 50 with a further case history of cancer, like prostatic adenocarcinoma , melanoma, and carcinoma

Ø    There are breast and/or ovarian cancers in multiple generations on an equivalent side of the family, like having both a grandmother and an aunt on the father’s side both diagnosed with these cancers

Ø    A woman is diagnosed with a second carcinoma within the same or the opposite breast or has both breast and ovarian cancer

Ø    blood brother is diagnosed with carcinoma

Ø    There may be a history of carcinoma , ovarian cancer, prostatic adenocarcinoma , and/or carcinoma on an equivalent side of the family

Ø    Having Ashkenazi Jewish ancestry




What causes HBOC?

HBOC is an inherited genetic condition. this suggests 
that the cancer risk is passed from generation to generation during a family. There are 2 primary genes linked with most families who have HBOC: BRCA1 and BRCA2. BRCA stands for carcinoma . A “mutation,” or harmful genetic change, in either BRCA1 or BRCA2 gives a lady an increased lifetime risk of developing breast and ovarian cancers. Men with these gene mutations even have an increased risk of carcinoma and prostatic adenocarcinoma . there's a small increase within the risk of other cancers including carcinoma and melanoma among people with BRCA1 or BRCA2 mutations.

Not all families with multiple cases of breast and ovarian cancer have mutations in BRCA1 or BRCA2. There also are 
other genes that are linked with an increased risk of developing breast and other cancers, like mutations within the TP53, PTEN, CDH1, ATM, CHEK2, or PALB2 tumor suppressor genes et al. . Blood tests now include many of those genes, including BRCA1 or BRCA2, during a single, multiple-gene panel test.

How is HBOC inherited?

Normally, everyone 
has 2 copies of every gene in their body’s cells: 1 copy is inherited from a person’s mother and 1 copy is inherited from a person’s father. HBOC follows an autosomal dominant inheritance pattern. this suggests that a mutation must happen in just 1 copy of the gene for the person to possess an increased risk of getting that disease. this suggests that a parent with a point mutation may pass along a replica of their normal gene or a replica of the gene with the mutation. Therefore, a toddler who features a parent with a mutation features a 50% chance of inheriting that mutation. A brother, sister, or parent of an individual who features a mutation also features a 50% chance of getting inherited an equivalent mutation. However, if the oldsters test negative for the mutation (meaning each person’s test results found no mutation), the danger to the siblings significantly decreases but their risk should be above a mean risk.


Can HBOC be avoided?

There are options available for people with HBOC who have an interest 
in having a toddler and reducing that child’s risk of this hereditary syndrome. Preimplantation genetic diagnosis (PGD) may be a procedure done along side in-vitro fertilization (IVF). It allows people that carry a selected known mutation to scale back the likelihood that their children will inherit the condition. For PGD, a woman’s eggs are removed and fertilized during a laboratory.


When the embryos reach a particular size, 1 cell is removed and tested for the precise genetic disease . the oldsters can then prefer to transfer the embryos that don't have the mutation. PGD has been used for over 2 decades for several hereditary cancer syndromes. However, it's a posh procedure with financial, physical, and emotional factors to think about before starting. For more information, talk with an assisted reproduction specialist at a fertility clinic.

Who should be tested for HBOC?

Most breast and ovarian cancers occur accidentally 
with no known cause, so testing for BRCA1 or BRCA2 gene mutations might not be beneficial for the typical woman. Genetic testing is suggested primarily for people that have a private and/or case history that means HBOC. However, women younger than 60 with triple-negative carcinoma (see above), are in danger of getting a BRCA mutation, no matter case history.

For women with a previous diagnosis of carcinoma 
or ovarian cancer and/or a case history of breast or ovarian cancer, the National Comprehensive Cancer Network (NCCN) provides recommendations for when guidance and testing could also be needed. These recommendations are supported your family’s history of cancer and the way closely related you're to the person(s) who developed cancer.


Ø  First-degree relatives include parents, siblings

Ø  Second-degree relatives include aunts/uncles, grandparents, grandchildren, and nieces/nephews.

Ø  Third-degree relatives include first-cousins, great-grandparents, or great-grandchildren.



How is HBOC identified?


Mutations within the 
BRCA1 or BRCA2 genes are often identified through a blood or saliva test. the standard method of testing, called standard gene sequencing, can find most BRCA mutations. There are other sorts of mutations called rearrangements, which include deletions or duplications in BRCA1 and BRCA2 that also may cause an increased risk for these cancers. Testing is additionally available for giant rearrangements in BRCA1 and BRCA2.

After initial BRCA1 and BRCA2 genetic testing, additional testing could also be 
recommended if:



Ø   The results were “negative,”


Ø    A variant of uncertain significance was detected, which suggests that there's a genetic change, but it's not known how that change could affect cancer risk




Notice: Please consult your doctor before following any instruction of

Copyright © 2019 by : MOD